|
|
Tuesday, March 30, 2004
Kemia Raises $33.5M
San Diego-based Kemia announced that it has raised $33.5M in a Series B, led by JPMorgan Partners. New investors Novo A/S and Hamilton Apex also participated, as well as all of the company's prior investors. Ron Ferguson of JPMorgan has also joined the company's board. Kemia is developing small molecule medicines targeted at inflammation, cancer, HIV, diabetes and bone diseases.
posted on Tuesday, March 30, 2004 (Link to more information)
|
RSS Feed
Newsletter
Previous news:
Monday, September 8, 2008
Friday, September 5, 2008
Thursday, September 4, 2008
Wednesday, September 3, 2008
Tuesday, September 2, 2008
|